Nektar Therapeutics (NASDAQ:NKTR) Cut to Sell at StockNews.com
StockNews.com cut shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) from a hold rating to a sell rating in a research note published on Wednesday morning. NKTR has been the subject of a number of other research reports. William Blair reissued a “market perform” rating on shares of Nektar Therapeutics in a research report on […]
StockNews.com cut shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) from a hold rating to a sell rating in a research note published on Wednesday morning. NKTR has been the subject of a number of other research reports. William Blair reissued a “market perform” rating on shares of Nektar Therapeutics in a research report on […]
